- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (68)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (26)
- Bladder Cancer (72)
- Brain Metastases (28)
- Brain Tumor (230)
- Breast Cancer (720)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (158)
- Colon Cancer (164)
- Colorectal Cancer (114)
- Endocrine Tumor (4)
- Esophageal Cancer (44)
- Eye Cancer (36)
- Fallopian Tube Cancer (8)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (8)
- Kidney Cancer (126)
- Leukemia (344)
- Liver Cancer (50)
- Lung Cancer (288)
- Lymphoma (284)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (98)
- Myelodysplastic Syndrome (60)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (100)
- Ovarian Cancer (172)
- Pancreatic Cancer (164)
- Parathyroid Disease (2)
- Penile Cancer (14)
- Pituitary Tumor (6)
- Prostate Cancer (144)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (238)
- Skin Cancer (296)
- Skull Base Tumors (56)
- Spinal Tumor (12)
- Stomach Cancer (62)
- Testicular Cancer (28)
- Throat Cancer (92)
- Thymoma (6)
- Thyroid Cancer (96)
- Tonsil Cancer (30)
- Uterine Cancer (80)
- Vaginal Cancer (16)
- Vulvar Cancer (20)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (10)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (632)
- Complementary Integrative Medicine (24)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (230)
- Epigenetics (6)
- Fertility (62)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (124)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (118)
- Molecular Diagnostics (8)
- Pain Management (62)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (916)
- Research (398)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (608)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (402)
- Survivorship (322)
- Symptoms (184)
- Treatment (1790)
Ovarian cancer survivor: How I turned a trip to MD Anderson for cancer treatment into a girls' weekend
3 minute read | Published April 02, 2014
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on April 02, 2014
When I told my friends about my ovarian cancer diagnosis, they had a lot of questions: What stage was my cancer? What was my ovarian cancer treatment plan? How often would I go to Houston? What was MD Anderson like?
I started a website to help keep everyone updated, but I knew none of my friends would be able to grasp how amazing MD Anderson is. I have never seen a hospital that big or experienced such a friendly and helpful staff. I told my friends that even though I was exhausted and didn't feel well, I still looked forward to my trips to Texas just because MD Anderson's staff made me so comfortable. They helped me cope with my fears about my upcoming surgery and chemotherapy.
After about five or six months of traveling for my ovarian cancer treatment, I decided to let one of my friends come along instead of my husband or parents. This was a chance to show off my hospital and let a friend gain a better understanding of what ovarian cancer treatment is like.
Traveling for ovarian cancer treatment with a friend
Before my next round of chemo, I invited my friend Melanie to travel with me.
With our flight and hotel booked, I warned her that Thursday would be a long day with blood work, appointments with doctors and then chemo. My body was becoming very sensitive to the Carboplatin, so treatments took anywhere from 7 to 12 hours. After we arrived at MD Anderson, I had my blood work done and then gave Melanie a tour and grabbed breakfast in the Waterfall Café in the Mays Clinic.
When we sat down to see the doctor, I was informed my white blood cell counts had dropped and were too low to receive chemo. Cue the tears.
After calming down and finishing the visit with my doctor, I apologized to Melanie for the breakdown. It was good she was there and was able to see some of my ups and downs. I wanted my friends to see me on the good days as well as the bad days, so they would have a better idea of what I was going through.
Finding fun during cancer treatment
I needed some retail therapy after hearing I wouldn't be getting my treatment this trip, so Melanie and I spent the rest of the day shopping and exploring Houston. We ended the day with a stop by my favorite bakery for cupcakes. To no surprise, Melanie loved them, too.
Bringing a friend along to MD Anderson made the trip feel different. It was fun to show Melanie around both the hospital and Houston, and our time together helped me forget about the seriousness of the trip and the letdown of not receiving chemo. It felt like a girls' trip. We laughed almost the entire time.
Now when I talk to Melanie about my trips to MD Anderson, she can actually visualize what I am talking about. She has a better idea of what I'm going through and better understands why MD Anderson is such a special place. This understanding has helped strengthen our friendship. Hopefully, we can plan another girls' trip sometime.

I wanted my friends to see me on the good days as well as the bad days, so they would have a better idea of what I was going through.
Brittany Hurst
Survivor